CVS HEALTH CORPORATION Interest Expense Nonoperating
CVS HEALTH CORPORATION (CVS) reported Interest Expense Nonoperating of $757.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- CVS HEALTH CORPORATION interest expense nonoperating for the quarter ending 2026-06-30 was $757.00M, a 0.79% decline year-over-year.
- CVS HEALTH CORPORATION interest expense nonoperating for the quarter ending 2026-03-31 was $774.00M, a 1.40% decline year-over-year.
- CVS HEALTH CORPORATION interest expense nonoperating for the quarter ending 2025-12-31 was $787.00M, a 3.83% increase year-over-year.
- CVS HEALTH CORPORATION interest expense nonoperating for the quarter ending 2025-09-30 was $784.00M, a 4.26% increase year-over-year.
- CVS HEALTH CORPORATION interest expense nonoperating for fiscal 2025 was $3.12B, a 5.44% increase from fiscal 2024.
- CVS HEALTH CORPORATION interest expense nonoperating for fiscal 2024 was $2.96B, a 11.29% increase from fiscal 2023.
- CVS HEALTH CORPORATION interest expense nonoperating for fiscal 2023 was $2.66B, a 16.22% increase from fiscal 2022.
- CVS HEALTH CORPORATION interest expense nonoperating for fiscal 2022 was $2.29B.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $757.00M 10-Q · filed 2026-08-05 | $1.53B 10-Q · filed 2026-08-05 | $2.32B derived: sum of 3 quarters · filed 2026-08-05 | $3.10B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $774.00M 10-Q · filed 2026-05-06 | $1.56B derived: sum of 2 quarters · filed 2026-05-06 | $2.35B derived: sum of 3 quarters · filed 2026-05-06 | $3.11B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $787.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.57B derived: sum of 2 quarters · filed 2026-02-10 | $2.33B derived: sum of 3 quarters · filed 2026-08-05 | $3.12B 10-K · filed 2026-02-10 |
| 2025-09-30 | $784.00M 10-Q · filed 2025-10-29 | $1.55B derived: sum of 2 quarters · filed 2026-08-05 | $2.33B 10-Q · filed 2025-10-29 | $3.09B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $763.00M 10-Q · filed 2026-08-05 | $1.55B 10-Q · filed 2026-08-05 | $2.31B derived: sum of 3 quarters · filed 2026-08-05 | $3.06B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $785.00M 10-Q · filed 2026-05-06 | $1.54B derived: sum of 2 quarters · filed 2026-05-06 | $2.29B derived: sum of 3 quarters · filed 2026-05-06 | $3.03B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $758.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.51B derived: sum of 2 quarters · filed 2026-02-10 | $2.24B derived: sum of 3 quarters · filed 2026-02-10 | $2.96B 10-K · filed 2026-02-10 |
| 2024-09-30 | $752.00M 10-Q · filed 2025-10-29 | $1.48B derived: sum of 2 quarters · filed 2025-10-29 | $2.20B 10-Q · filed 2025-10-29 | $2.89B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $732.00M 10-Q · filed 2025-07-31 | $1.45B 10-Q · filed 2025-07-31 | $2.14B derived: sum of 3 quarters · filed 2026-02-10 | $2.83B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $716.00M 10-Q · filed 2025-05-01 | $1.41B derived: sum of 2 quarters · filed 2026-02-10 | $2.10B derived: sum of 3 quarters · filed 2026-02-10 | $2.79B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $690.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.38B derived: sum of 2 quarters · filed 2026-02-10 | $2.07B derived: sum of 3 quarters · filed 2026-02-10 | $2.66B 10-K · filed 2026-02-10 |
| 2023-09-30 | $693.00M 10-Q · filed 2024-11-06 | $1.38B derived: sum of 2 quarters · filed 2024-11-06 | $1.97B 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $686.00M 10-Q · filed 2024-08-07 | $1.27B 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | $2.29B 10-K · filed 2025-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |